What is Zepp Labs?
Zepp Labs, formerly known as Huami Corp., operates at the intersection of consumer electronics and health informatics. Since its inception in 2013, the company has established itself as a global leader in the development of smart wearables, shipping millions of units annually. Its core competency lies in the synthesis of hardware and software, specifically through the creation of proprietary AI chips, biometric sensors, and sophisticated data analytics platforms. By focusing on the nexus of health and technology, Zepp Labs provides actionable insights for both individual users and large-scale population health initiatives, effectively transforming raw biometric data into meaningful wellness outcomes.
How much funding has Zepp Labs raised?
Zepp Labs has raised a total of $21M across 3 funding rounds:
Other Financing Round
$1M
Series A
$5M
Series B
$15M
Other Financing Round (2012): $1M with participation from Cherubic Ventures
Series A (2013): $5M led by Legend Capital
Series B (2014): $15M supported by GGV Capital and Legend Capital
Key Investors in Zepp Labs
Cherubic Ventures
An early-stage venture capital firm based in Silicon Valley and Greater China that partners with visionary founders from angel to pre-IPO stages.
Legend Capital
A long-standing private equity fund manager and member of Legend Holdings, focusing on innovation and growth enterprises within the Chinese market.
GGV Capital
A global multi-stage venture firm that invests in seed-to-growth stage companies across the Social, Enterprise Tech, and Smart Tech sectors.
What's next for Zepp Labs?
Looking ahead, the strategic deployment of the $15M is expected to accelerate the company's R&D initiatives, particularly in the refinement of its AI-driven health monitoring capabilities. As the wearable market matures, Zepp Labs is likely to prioritize the expansion of its data analytics services, moving beyond simple fitness tracking toward comprehensive health management solutions. The firm's ability to leverage its existing infrastructure in the U.S. and China will be critical as it navigates the complexities of global regulatory environments and seeks to capture a larger share of the enterprise-level health technology market. Continued focus on innovation in biometric sensing will remain the primary driver for sustained competitive advantage.
See full Zepp Labs company page
